7 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35428182 | Ropivacaine inhibits wound healing by suppressing the proliferation and migration of keratinocytes via the PI3K/AKT/mTOR Pathway. | 2022 Apr 15 | 4 |
2 | 34696683 | Ropivacaine suppresses tumor biological characteristics of human hepatocellular carcinoma via inhibiting IGF-1R/PI3K/AKT/mTOR signaling axis. | 2021 Dec | 5 |
3 | 32606749 | Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K/AKT Signaling via miR-520a-3p. | 2020 | 1 |
4 | 29549929 | Local Anesthetic Drug Inhibits Growth and Survival in Chronic Myeloid Leukemia Through Suppressing PI3K/Akt/mTOR. | 2018 Mar | 5 |
5 | 29997943 | Suppression of mitochondrial respiration with local anesthetic ropivacaine targets breast cancer cells. | 2018 May | 2 |
6 | 26475807 | Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase. | 2015 Nov | 2 |
7 | 24525631 | Endothelial barrier protection by local anesthetics: ropivacaine and lidocaine block tumor necrosis factor-α-induced endothelial cell Src activation. | 2014 Jun | 2 |